Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Frontiers in Cardiovascular Medicine|December 12, 2022
An unusual contrast-induced encephalopathy following percutaneous coronary intervention in patients with cerebrovascular abnormalities: A case reportJiangquan Liao, Yan Wang, Mingjing Shao, et al.
Cancer Communications (London, England)|November 1, 2022
Targeting RAS mutants in malignancies: successes, failures, and reasons for hopeHang Yang, Xinyi Zhou, Dongliang Fu, et al.
Journal of Oncology|November 5, 2020
An Autophagy-Related Long Noncoding RNA Signature Contributes to Poor Prognosis in Colorectal CancerJingsun Wei, Xiaoxu Ge, Yang Tang, et al.
Cancer Letters|October 7, 2023
Rigosertib promotes anti-tumor immunity via autophagic degradation of PD-L1 in colorectal cancer cellsXinyi Zhou, Dongliang Fu, Hang Yang, et al.
Journal of Cellular and Molecular Medicine|April 3, 2025
NUPR1 Promotes Radioresistance in Colorectal Cancer Cells by Inhibiting FerroptosisYimin Fang, Haiyan Chen, Yunhua Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 8, 2021
Exosomal ANGPTL1 attenuates colorectal cancer liver metastasis by regulating Kupffer cell secretion pattern and impeding MMP9 induced vascular leakinessKai Jiang, Haiyan Chen, Yimin Fang, et al.
Cancer Biology & Medicine|August 4, 2021
Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of <i>KRAS</i>-mutant colorectal cancerXinyi Zhou, Qian Xiao, Dongliang Fu, et al.
Pageof 4